PET Imaging of Peripheral Benzodiazepine Receptors
NCT00696371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2019-12-17
Summary
This study will use positron emission tomography (PET) to measure a receptor in the brain that is involved in inflammation. It will test two radioactive chemicals used in the procedure to see if the newer chemical, \[(11)C\]B, is as good or better than the older one, \[(11)C\]A, for measuring brain inflammation.
Healthy volunteers 18 years of age and older may be eligible for this study. Participants undergo an evaluation, \[(11)C\]A PET scan, \[(11)C\]B PET scan and magnetic resonance imaging (MRI), as follows:
Evaluation
Medical history and physical examination, blood and urine tests
PET scans
* \[(11)C\]A scan. A catheter (plastic tube) is placed in an arm vein for injection of the \[(11)C\]A isotope. Some patients also have a catheter placed in an artery in the wrist to collect arterial blood samples during the scan. Subjects then lie on the scanner bed and a special mask is fitted to the head to help keep the subject s head still during the procedure. Following an 8-minute scan to calibrate the scanner, the \[(11)C\]A is injected into the catheter in the vein and pictures are taken that show where chemicals related to inflammation are present. The procedure takes about 2.5 hours.
* \[(11)C\]B scan. The procedure is the same as above for \[(11)C\]A, except the isotope used is \[(11)C\]B.
MRI scan.
This test uses a strong magnetic field and radio waves to obtain images of body organs and tissues. The subject lies on a table that can slide in and out of the scanner (a metal cylinder), wearing earplugs to muffle loud noises that occur during the scan.
...
Conditions
- Healthy
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Principal Investigators
-
William C Kreisl, M.D. · National Institute of Mental Health (NIMH)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-06-06
- Completion
- 2014-08-19
Countries
- United States
Study Locations
More Related Trials
-
PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP
NCT00598390 ·Status: COMPLETED ·Phase: PHASE1
-
PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram
NCT00250172 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2
NCT00598286 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
NCT00432900 ·Status: COMPLETED ·Phase: PHASE1
-
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
NCT00459693 ·Status: TERMINATED ·Phase: NA
-
Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112
NCT00088517 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of P-glycoprotein Function Using [11C]dLop
NCT00605254 ·Status: COMPLETED
-
PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers
NCT01826110 ·Status: COMPLETED ·Phase: PHASE1
-
Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment.
NCT03514524 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Normal Binding of R-[11C]PK11195 in Human Subjects
NCT00205595 ·Status: UNKNOWN ·Phase: PHASE1
-
Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain
NCT00788801 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
NCT05337774 ·Status: TERMINATED ·Phase: PHASE1
-
Imaging of Cannabinoid Receptors Using New Radioactive Tracer
NCT00450021 ·Status: COMPLETED ·Phase: PHASE1
-
Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease
NCT04057807 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET
NCT01719497 ·Status: COMPLETED
-
Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy
NCT02003183 ·Status: COMPLETED
-
PET Tau - Neurodegenerative Disease Imaging
NCT03143374 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT01209156 ·Status: COMPLETED ·Phase: PHASE1
-
Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers
NCT00531193 ·Status: COMPLETED ·Phase: PHASE1
-
PET Scan in Patients With Neurocardiologic Disorders
NCT00001418 ·Status: COMPLETED
-
Brain Imaging Biomarkers of Pathological Brain Aging in Late-life Depression
NCT03849417 ·Status: RECRUITING
-
PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects
NCT06299410 ·Status: RECRUITING ·Phase: PHASE1
-
The Influence of Pressure Pain on [11C]Diprenorphine Binding Potentials
NCT01546155 ·Status: COMPLETED ·Phase: NA
-
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
NCT06920628 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in Brain
NCT01896843 ·Status: COMPLETED ·Phase: PHASE1